Cooley advised Dutch Bros, and Latham & Watkins advised the underwriters. Dutch Bros Inc. (NYSE: BROS; Dutch Bros) announced the pricing of an underwritten offering of...
You must be a Standard 1 Year member to access this content.
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Helion Energy on the deal while Goodwin Procter represented Sam Altman as lead investor. Helion Energy, a clean energy company committed to creating...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering, while Cooley advised Dutch Bros. McDermott Will & Emery represented Travis Boersma, the Co-Founder of Dutch Bros....
You must be a Standard 1 Year member to access this content.
